Value of plasma chitotriosidase to assess non‐neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy
Crossref DOI link: https://doi.org/10.1007/s10545-014-9711-x
Published Online: 2014-05-16
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
van Dussen, L.
Hendriks, E. J.
Groener, J. E. M.
Boot, R. G.
Hollak, C. E. M.
Aerts, J. M. F. G.
Version of Record valid from 2014-05-16